Safinamide: an add-on treatment for managing Parkinson’s disease

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

INDOCYANINE GREEN IMAGING BY VITAL TISSUE SLICES SCANNING ALLOWS FOR THE ISOLATION OF INTACT LIVER MICRO-METASTASIS FOR SINGLE-CELL ANALYSIS

Preprint in bioRxiv (June 2023)

Pharmacokinetic and Safety Study of Single and Multiple Oral Doses of Safinamide in Healthy Chinese Volunteers

Article in Clinical Pharmacology in Drug Development (June 2023)

The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update

Article in CNS & Neurological Disorders - Drug Targets (January 2023)